Esther Raskopf

9PUBLICATIONS
28CO-AUTHORS
AllergyGene and molecular therapyMedical molecular engineering of nucleic acids and proteinsNaturopathyCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 04, 2026
Short-Course Subcutaneous Immunotherapy With Mannan-Conjugated Birch Pollen Allergoids: Consistent Clinical and Immunological Improvements.

|Apr 30, 2026
Sustained Clinical Improvement in Birch Pollen Allergy After Two Pre-Seasonal Short Courses of Allergen-Specific Immunotherapy: A Long-Term Open-Label Extension Study.

|Nov 09, 2024
Short-course subcutaneous treatment with birch pollen allergoids greatly improves symptom and medication scores in birch allergy.

Ralph Mösges, Esther Raskopf, Ludger Klimek

|Oct 12, 2023
A randomized, double-blind, placebo-controlled trial with mannan-conjugated birch pollen allergoids.

Ralph Mösges, Christoph Zeyen, Esther Raskopf

|Sep 15, 2021
A meta-analysis on allergen-specific immunotherapy using MCT® (MicroCrystalline Tyrosine)-adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis.

Sven Becker, Petra Zieglmayer, Gabriela Canto

|Apr 26, 2021
Effects of ectoine containing nasal spray and eye drops on symptoms of seasonal allergic rhinoconjunctivitis.

Anne M Salapatek, Nina Werkhäuser, Basma Ismail

Pageof 2

Frequent Collaborators

8 joint publications

Ralph Mösges

4 joint publications

Cengizhan Acikel

4 joint publications

Miguel Casanovas

4 joint publications

José Luis Subiza